2024
IR 2024/09/17
IR 2024/09/17
Notice Regarding an Additional Financial Contribution to the ESOP Trust
IR 2024/09/05
Annual Securities Report For the 78th business term (April 1, 2023 to March 31, 2024)
IR 2024/08/01
Consolidated Financial Result Digest FY2025/3 Q1 (Fiscal Year Ended March 31, 2025)
IR 2024/08/01
IR 2024/08/01
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025
IR 2024/07/09
IR 2024/06/27
IR 2024/06/20
IR 2024/06/17
IR 2024/06/17
IR 2024/06/17
IR 2024/06/17
IR 2024/06/15
Notice of resolutions at 78th Ordinary General Shareholders’ Meeting
IR 2024/06/14
Notice Regarding Launch of “MADOPAR® Combination Tablets L50” for a Treatment of Parkinsonism
IR 2024/06/13
[Delayed]Notice Regarding Partial Amendment of the Articles of Incorporation
IR 2024/06/13
[Delayed]Notice Regarding Company’s Propositions For 78th Ordinary General Shareholders’ Meeting
IR 2024/05/23
IR 2024/05/13
IR 2024/05/13
Notice Regarding the Change of the Candidates for Board Directors
IR 2024/05/01
IR 2024/05/01
Consolidated Financial Result Digest FY2024/3 Q4 (Fiscal Year Ended March 31, 2024)
IR 2024/05/01
IR 2024/05/01
IR 2024/05/01
Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
IR 2024/04/10
IR 2024/04/01
Notice regarding acquisition and acquisition completion of Treasury Stock
IR 2024/03/21
IR 2024/03/15
IR 2024/03/15
IR 2024/03/08
IR 2024/02/15
IR 2024/02/09
IR 2024/02/02
Consolidated Financial Result Digest FY2024/3 Q3 (Fiscal Year Ended March 31, 2024)
IR 2024/02/02
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ended March 31, 2024
IR 2024/01/31
IR 2024/01/10
2023
IR 2023/12/08
IR 2023/11/10
IR 2023/11/06
IR 2023/11/06
Consolidated Financial Result Digest FY2024/3 Q2 (Fiscal Year Ended March 31, 2024)
IR 2023/11/06
IR 2023/11/06
Consolidated Financial Results for the First Six Months of the Fiscal Year Ended March 31, 2024
IR 2023/10/10
IR 2023/09/20
Annual Securities Report For the 77th business term (April 1, 2022 to March 31, 2023)
IR 2023/09/14
IR 2023/09/14
IR 2023/09/14
Notice Regarding Transition to Company with Audit & Supervisory Committee
IR 2023/09/08
IR 2023/08/31
IR 2023/08/10
IR 2023/08/10
Taiyo Holdings Selected as a Constituent of the JPX Nikkei Index 400 for the First Time
IR 2023/08/01
Consolidated Financial Result Digest FY2024/3 1Q(Fiscal Year Ended March 31, 2024)
IR 2023/08/01
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2024
IR 2023/07/14
IR 2023/07/10
IR 2023/06/27
IR 2023/06/19
IR 2023/06/19
IR 2023/06/17
Notice of resolutions at 77th Ordinary General Shareholders’ Meeting
IR 2023/05/25
IR 2023/05/12
(Corrections) Partial correction of “Notice regarding personnel changes”
IR 2023/05/12
IR 2023/05/12
IR 2023/05/12
Notice Regarding Company’s Propositions For 77th Ordinary General Shareholders’ Meeting
IR 2023/05/01
Notice regarding introduction of entrusted Executive Officer system
IR 2023/05/01
IR 2023/05/01
Consolidated Financial Result Digest FY2022 Q4 (Fiscal Year Ended March 31, 2023)
IR 2023/05/01
Consolidated Financial Results for the Fiscal Year Ended March 31, 2023
IR 2023/04/24
IR 2023/04/03
Notice of Transfer of REMINYL® (galantamine) products in Japan
INFO 2023/03/27
【TAIWAN TAIYO INK】Notice of Opening of “Taipei Sales Office”
IR 2023/03/17
IR 2023/03/17
IR 2023/03/17
Notice of Revised Earnings Forecasts for the Fiscal Year Ending March 2023
IR 2023/02/10
Consolidated Financial Result Digest FY2023 Q3 (Fiscal Year Ending March 31, 2023)
IR 2023/02/10
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
IR 2023/02/07
2022
INFO 2022/12/13
Taiyo Holdings Signs Sponsorship Deal with Skateboarder Yuro Nagahara
IR 2022/11/16
Notice regarding acquisition and acquisition completion of Treasury Stock
IR 2022/11/10
IR 2022/11/07
Notice Regarding Disclosure of Information Based on TCFD Recommendations
IR 2022/11/07
Consolidated Financial Result Digest FY2023/3 2Q (Fiscal Year Ending March 31, 2023)
IR 2022/11/07
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2023
IR 2022/10/07
IR 2022/09/16
Notice regarding organizational changes and personnel changes
IR 2022/09/09
Annual Securities Report for the 76th business term (April 1, 2021, to March 31, 2022)
IR 2022/09/09
IR 2022/08/22
IR 2022/08/10
IR 2022/08/10
IR 2022/08/05
Notice Regarding Responses to Questions Received Upon Application to View Internet Stream
IR 2022/07/27
IR 2022/07/27
Consolidated Financial Result Digest FY2023/3 1Q (Fiscal Year Ending March 31, 2023)
IR 2022/07/27
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2023
IR 2022/07/08
IR 2022/06/20
IR 2022/06/20
IR 2022/06/20
IR 2022/06/20
IR 2022/06/18
Notice of resolutions at 76th Ordinary General Shareholders’ Meeting
IR 2022/06/10
IR 2022/06/06
IR 2022/05/26
IR 2022/05/25
NOTICE REGARDING COMPANY’S PROPOSITIONS FOR 76TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
IR 2022/05/12
Notice regarding Candidate for Chairman of the Board of Directors
IR 2022/05/12
IR 2022/05/10
IR 2022/04/28
Notice regarding organizational changes and personnel changes
IR 2022/04/28
IR 2022/04/28
Notice regarding Director and Audit & Supervisory Board Member candidates
IR 2022/04/28
Consolidated Financial Result Digest FY2022 Q4 (Fiscal Year Ended March 31, 2022)
IR 2022/04/28
IR 2022/04/28
Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
IR 2022/04/08
IR 2022/03/18
Notice regarding organizational changes and personnel changes
IR 2022/03/18
IR 2022/03/16
IR 2022/02/25
IR 2022/02/14
Notice regarding acquisition and acquisition completion of Treasury Stock
IR 2022/02/10
IR 2022/02/08
Consolidated Financial Result Digest FY2022 Q3 (Fiscal Year Ending March 31, 2022)
IR 2022/02/08
IR 2022/02/08
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2022
INFO 2022/01/21
Sponsorship Deal with Pro Athlete Nozomi Okuhara (Badminton) Renewed through 2024
IR 2022/01/07
2021
IR 2021/12/10
IR 2021/12/02
IR 2021/11/10
IR 2021/11/05
Consolidated Financial Result Digest FY2022 Q2 (Fiscal Year Ending March 31, 2022)
IR 2021/11/05
IR 2021/11/05
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2022
IR 2021/10/08
IR 2021/10/01
Annual Securities Report for the 75th business term (April 1, 2020, to March 31, 2021)
IR 2021/09/17
Notice Regarding an Application to Select the New Market Segment, Prime Market
IR 2021/09/10
IR 2021/08/12
Notice Regarding Compliance with Listing Maintenance Criteria for New Market Segment “Prime Market”
IR 2021/08/12
IR 2021/08/10
IR 2021/08/04
IR 2021/08/02
IR 2021/08/02
IR 2021/08/02
Notice of Revised Forecasts for the second quarter of FY2022 and for the full year of FY2022
IR 2021/08/02
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2022
IR 2021/07/09
IR 2021/06/28
IR 2021/06/28
IR 2021/06/10
Briefing Material on the Long-Term Management Plan held on Monday, June 7, 2021
INFO 2021/06/10
IR 2021/06/10
IR 2021/06/04
IR 2021/05/27
IR 2021/05/12
IR 2021/05/10
IR 2021/04/30
IR 2021/04/30
Consolidated Financial Result Digest FY2021 Q4 (Fiscal Year Ending March 31, 2021)
IR 2021/04/30
Consolidated Financial Results for the Fiscal Year Ended March 31, 2021
IR 2021/04/16
Notice regarding acquisition of a distribution center by our Consolidated Subsidiary
IR 2021/03/29
Notice regarding organizational changes and personnel changes
IR 2021/03/29
IR 2021/03/23
Notice regarding acquisition and acquisition completion of Treasury Stock
IR 2021/03/22
IR 2021/03/10
IR 2021/02/10
IR 2021/02/05
Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021
IR 2021/02/05
IR 2021/02/05
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2021
IR 2021/01/08
2020
IR 2020/12/21
IR 2020/12/21
Notice regarding organizational changes and personnel changes
IR 2020/12/10
IR 2020/12/01
IR 2020/12/01
IR 2020/12/01
Notice regarding organizational changes and personnel changes
IR 2020/11/06
IR 2020/11/06
Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021
IR 2020/11/06
IR 2020/11/06
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2021
IR 2020/10/16
IR 2020/10/09
IR 2020/09/28
IR 2020/08/31
Annual Securities Report for the 74rd business term (April 1, 2019 to March 31, 2020)
IR 2020/08/31
IR 2020/08/21
IR 2020/08/21
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2021
IR 2020/08/13
IR 2020/08/13
IR 2020/08/06
INFO 2020/07/31
Taiyo Ink MFG participates in Apple’s Clean Energy Program 2020
INFO 2020/07/31
Sponsorship Deal with Pro Athlete Nozomi Okuhara (Badminton) Renewed through 2021
IR 2020/07/13
IR 2020/06/15
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2020
IR 2020/06/11
Consolidated Financial Results for the Fiscal Year Ended March 31,2020
IR 2020/05/28
IR 2020/02/19
IR 2020/02/19
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2020
2019
IR 2019/12/12
INFO 2019/11/19
TAIYO INK joining the exhibition, “IDTechEX Show !” in Santa Clara, CA, USA
IR 2019/11/18
IR 2019/11/14
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2020
IR 2019/11/05
IR 2019/11/05
IR 2019/08/20
IR 2019/08/20
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2020
IR 2019/08/20
Annual Securities Report for the 73rd business term (April 1, 2018 to March 31, 2019)
IR 2019/06/14
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31,2019
IR 2019/06/04
IR 2019/06/04
Consolidated Financia Results for the Fiscal Year Ended March 31,2019
IR 2019/05/30
INFO 2019/04/22
「Taiyo Ink MFG participates in Apple’s Clean Energy Program 2019」
IR 2019/03/25
IR 2019/03/25
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019
IR 2019/03/25
Notice of Capital and Business Alliance with Cyfuse Biomedical K.K.
IR 2019/03/22
IR 2019/02/14
INFO 2019/01/11
Sponsorship Deal with Rio Olympic Medalist Nozomi Okuhara (Badminton)
IR 2019/01/08
2018
IR 2018/12/04
IR 2018/11/29
IR 2018/11/29
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2019
INFO 2018/11/08
TAIYO INK joining the exhibition, “IDTechEX Show !” in Santa Clara, CA, USA
IR 2018/09/05
Annual Securities Report for the 72nd business term (April 1, 2017 to March 31, 2018)
IR 2018/08/31
IR 2018/08/16
IR 2018/08/16
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2019
IR 2018/08/08
Shared Research Flash Report has been updated (Q1 FY03/19 Flash Update)
IR 2018/06/26
IR 2018/06/05
IR 2018/05/30
IR 2018/05/22
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2018
IR 2018/05/22
Consolidated Financial Results for the Fiscal Year Ended March 31, 2018
IR 2018/03/30
INFO 2018/03/28
TAIYO INK joining the exhibition, “IDTechEX Show !” in Berlin, Germany
IR 2018/02/14
IR 2018/02/14
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018
IR 2018/01/05
2017
IR 2017/11/28
IR 2017/11/28
Notice Regarding Correction to Taiyo Holdings’ Annual Report 2017
IR 2017/11/20
IR 2017/11/20
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2018
IR 2017/11/14
IR 2017/11/14
Marketing and Manufacturing Rights Transfer of 13 Long-Term Listed Products
IR 2017/08/09
IR 2017/08/09
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2018
IR 2017/06/15
IR 2017/06/14
IR 2017/05/22
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2017
IR 2017/05/22
Consolidated Financial Results for the Fiscal Year Ended March 31, 2017
INFO 2017/04/25
TAIYO INK joining the conference/ exhibition “2017 FLEX” in Monterey, California
INFO 2017/04/25
TAIYO INK joining the exhibition “Wearable Europe 2017” in Berlin, Germany
IR 2017/02/07
IR 2017/02/07
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2017
IR 2017/02/02
2016
IR 2016/11/11
IR 2016/11/11
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2017
IR 2016/11/02
IR 2016/08/10
IR 2016/08/10
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2017
INFO 2016/06/06
IR 2016/05/17
Consolidated Financial Results for the Fiscal Year Ending March 31, 2016
IR 2016/05/17
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2016
IR 2016/02/09
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2016
IR 2016/02/09
2015
IR 2015/12/22
IR 2015/11/11
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2016
IR 2015/11/11
IR 2015/08/07
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2016
IR 2015/08/07
IR 2015/05/21
Consolidated Financial Results for the Fiscal Year Ending March 31, 2015
IR 2015/05/21
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2015
IR 2015/02/09
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2015
IR 2015/02/09
2014
IR 2014/11/17
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2015
IR 2014/11/17
IR 2014/10/17
IR 2014/08/20
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2015
IR 2014/08/20
IR 2014/05/22
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2014
IR 2014/05/22
Consolidated Financial Results for the Fiscal Year Ending March 31, 2014
IR 2014/02/17
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2014
IR 2014/02/17
2013
IR 2013/12/06
IR 2013/11/26
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2014
IR 2013/11/26
IR 2013/08/27
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2014
IR 2013/08/27
IR 2013/05/27
Consolidated Financial Results for the Fiscal Year Ending March 31, 2013
IR 2013/05/27
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2013
IR 2013/02/19
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2013
IR 2013/02/14
2012
IR 2012/11/22
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2013
IR 2012/11/22
IR 2012/10/19
IR 2012/08/09
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2013
IR 2012/08/09
IR 2012/05/30
Consolidated Financial Results for the Fiscal Year Ending March 31, 2012
IR 2012/05/30
Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2012
IR 2012/02/17
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2012
IR 2012/02/17
2011
IR 2011/11/22
IR 2011/11/17
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2012
IR 2011/09/09
IR 2011/09/01
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2012
IR 2011/08/09
IR 2011/05/30
Consolidated Financial Results for the Fiscal Year Ended March 31, 2011
IR 2011/05/30
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2011
IR 2011/02/18
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2011
IR 2011/02/18
2010
IR 2010/12/10
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2011
IR 2010/12/10
IR 2010/08/27
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2011
IR 2010/08/27
IR 2010/07/06
IR 2010/06/14
Consolidated Financial Results for the Fiscal Year Ended March 31, 2010
IR 2010/06/14
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2010
IR 2010/05/17
IR 2010/05/17
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2010
2009
IR 2009/11/19
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2010
IR 2009/11/19
IR 2009/09/02
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2010
IR 2009/09/02
IR 2009/06/19
Consolidated Financial Results for the Fiscal Year Ended March 31, 2009
IR 2009/06/19
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2009
IR 2009/03/03
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2009
IR 2009/03/03
2008
IR 2008/12/12
Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2009
IR 2008/12/12
IR 2008/08/13